Literature DB >> 6168512

Antigenicity of desamido-insulin and monocomponent insulin.

T Kasama, Y Iwata, K Oshiro, M Uchida, Y Sakaguchi, K Namie, M Sugiura.   

Abstract

No consensus about the antigenicity of monocomponent insulin has yet been reached. We have therefore administered different insulin preparations to rabbits and rats to determine IgG and IgE antibody production. The preparations used were porcine monocomponent insulin, conventional bovine and porcine insulin powders, porcine b-component and synthesized porcine mono-desamido-insulin and hexa-desamido-insulin. In rabbits, porcine b-component was the most antigenic preparation, followed by conventional bovine and porcine insulins. No antibody production was observed with the other preparations. In rats the 60 h passive cutaneous anaphylaxis test showed virtually no insulin IgE antibody production in response to porcine monocomponent insulin. However, if porcine b-component or porcine hexa-desamido-insulin was employed both for sensitisation and as the challenging antigen, positive skin reactions were observed with demonstration of insulin IgE antibodies. Our results confirm the low antigenicity of the pharmaceutical preparation of porcine monocomponent insulin and suggest that porcine hexa-desamido-insulin and porcine b-component administration may result in the production of reagin-type antibodies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168512     DOI: 10.1007/BF03216227

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Separation and characterization of acid-induced insulin transformation products by paper electrophoresis in 7 M urea.

Authors:  F SUNDBY
Journal:  J Biol Chem       Date:  1962-11       Impact factor: 5.157

2.  Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction.

Authors:  Z OVARY
Journal:  Prog Allergy       Date:  1958

3.  Studies on the amide and C-terminal residues in proteins. 2. The ammonia nitrogen and amide nitrogen of various native protein preparations.

Authors:  A C CHIBNALL; J L MANGAN; M W REES
Journal:  Biochem J       Date:  1958-01       Impact factor: 3.857

4.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

5.  Reaginic antibody against insulin: demonstra- tion of antigenic distinction between native and extracted insulin.

Authors:  R Patterson; G Lucena; R Metz; M Roberts
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

6.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

Authors:  K Weber; J R Pringle; M Osborn
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

7.  Clinical aspects of insulin--antigenicity.

Authors:  J Schlichtkrull; J Brange; A H Christiansen; O Hallund; L G Heding; K H Jorgensen
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

8.  Determination of purity and identification of animal sources of insulin in various insulin preparations.

Authors:  T Kasama; Y Iwata; T Okubo; Y Sakaguchi; M Sugiura
Journal:  Jpn J Pharmacol       Date:  1980-06

9.  The influence of insulin and insulin antibodies on the glomerular structure.

Authors:  H Wehner
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1976

10.  [The antigenicity of various new chromatographically purified depot insulin preparations].

Authors:  D Graber; S Fankhauser
Journal:  Schweiz Med Wochenschr       Date:  1978-11-18
View more
  3 in total

1.  Chemical stability of insulin in a delivery system environment.

Authors:  U Grau
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

2.  The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model.

Authors:  J L Ottesen; P Nilsson; J Jami; D Weilguny; M Dührkop; D Bucchini; S Havelund; J M Fogh
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

3.  Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices.

Authors:  N Jeandidier; S Boivin; R Sapin; F Rosart-Ortega; B Uring-Lambert; P Réville; M Pinget
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.